Physician profile
Aariel L Dees
NPI 1770107070
$3,649.87
in general payments reported to CMS, 2019-2025
12 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.00 · 2024: $1,664 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $550.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $218.21 | 2024-2025 | Myfembree, Gemtesa |
| Genmab U.S., INC. | $99.00 | 2021 | |
| Astellas Pharma US INC | $70.77 | 2024-2025 | Veozah |
| Millicent US INC | $56.23 | 2025 | Femlyv |
| Exeltis, USA INC. | $43.74 | 2024-2025 | Slynd |
| Smith+Nephew, INC. | $43.59 | 2024 | Pico |
| Bayer Healthcare Pharmaceuticals INC. | $32.90 | 2025 | |
| Hologic Sales and Service, LLC | $26.89 | 2024 | Aptima |
| Novo Nordisk INC | $24.50 | 2025 | Wegovy |
| Mayne Pharma Commercial LLC | $18.96 | 2025 | |
| Convatec INC. | $15.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aariel Dees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.